MARKET

JAGX

JAGX

Jaguar Health Inc
NASDAQ
4.530
-0.470
-9.40%
After Hours: 4.659 +0.129 +2.85% 19:05 10/08 EDT
OPEN
4.820
PREV CLOSE
5.00
HIGH
4.940
LOW
4.365
VOLUME
585.53K
TURNOVER
--
52 WEEK HIGH
1,267.88
52 WEEK LOW
2.350
MARKET CAP
9.69M
P/E (TTM)
-0.0008
1D
5D
1M
3M
1Y
5Y
1D
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 2d ago
Jaguar Health Shares Jump As Napo Showcases Intestinal Failure Program At Abu Dhabi Conference
NASDAQ · 2d ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 2d ago
Why Option Care Health Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket
Benzinga · 2d ago
Jaguar Health (JAGX) Stock Climbs Over 34% After-Hours: What's Going On?
Benzinga · 2d ago
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 3d ago
Jaguar Health announces special stock dividend
TipRanks · 3d ago
Jaguar Health Declares Special Series R Preferred Dividend
TipRanks · 3d ago
More
About JAGX
Jaguar Health, Inc. is a commercial stage pharmaceuticals company. The Company is developing prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress, specifically associated with overactive bowel, which includes symptoms such as chronic debilitating diarrhea, urgency, bowel incontinence, and cramping pain. Its marketed drug Mytesi, (crofelemer 125 mg delayed-release tablets), is a first-in-class oral botanical drug product approved by the FDA for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. Its Canalevia-CA1, crofelemer delayed-release tablets drug, is an oral plant-based prescription product that is FDA conditionally approved to treat chemotherapy-induced diarrhea in dogs. It has an exclusive distribution agreement for the sale of Gelclair. It is developing a pipeline of prescription drug product candidates to address unmet needs in gastrointestinal health.

Webull offers Jaguar Health Inc stock information, including NASDAQ: JAGX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JAGX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading JAGX stock methods without spending real money on the virtual paper trading platform.